Pharmaceutical corporate patent strategy and innovation capacity-building under the framework of the strategic emerging industries / 中国药学杂志

ABSTRACT

OBJECTIVE: To provide domestic innovative pharmaceutical enterprises practical advice on patent strategy and innovation capacity-building. METHODS: Choose the first class innovative drug NBP as study subject, make an empirical study from three aspects, including patent creation, management and implementation, about how to take full advantage of the national innovation policies and patent strategy to improve the innovation capability of enterprises to ensure its sustainable development. RESULTS: The patent strategy of NBP turns out to be a very big success. CONCLUSION: CSPC has developed a virtuous cycle, in which patent strategy and innovation capacity-building facilitate each other, its successful experience is worth learning for high-tech enterprises.